Oral Chemotherapy Adherence Intervention for Cancer Patients
This study is testing a new program called the Multilevel Adherence Intervention to help people with cancer take their oral anticancer agents (chemotherapy pills) correctly. The program involves personalized counseling sessions with a clinical pharmacist. These pharmacists will help you understand how to take your medication, manage side effects, and plan your treatment. The study aims to see how well this program works and how easy it is to use. We are looking for 160 adults, aged 21 or older, who have either solid tumors or blood cancers (hematologic malignancies) and have been taking oral anticancer agents for at least six months. The study will measure how well people stick to their medication schedule and how acceptable and appropriate the program is.
- Study design
- This study will include 160 participants and will compare two groups: one group before the program was implemented and another group who has been in the program for at least six months.
- What's involved
- You will have individualized counseling sessions with a clinical pharmacist, who will review your medication and provide ongoing support. Your interactions with the pharmacist will vary based on your monitoring risk category.
- Compensation
- Not stated in the trial record.
- Follow-up
- The study will measure acceptability and appropriateness after 6 months.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Implementation of an Oral Chemotherapy Adherence Intervention
At a glance
Conditions
NCT06989489
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
UNC Chapel Hill
Chapel Hill, North Carolinastudy coordinator listed
Recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Benyam Muluneh, PharmD · PRINCIPAL_INVESTIGATOR · UNC Lineberger Comprehensive Cancer Center
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Oral Medication AdherenceBaseline and week 4
Patient's medication adherence of their oral anticancer regiment will be quantified using the PROMIS- medication adherence Likert-type questionnaire, from strongly disagree to strongly agree. Score will change from 1 to 5, with a maximum of 50 and minimum of 10. A higher score reflects better adherence. These answers will help the investigators see if the program was effective in helping the patient's medication adherence.
- AcceptabilityAfter 6 months
A study specific survey will be used to measure acceptability. Survey will have Likert-type questions, 1-5 strongly disagree to strongly agree, a higher score reflects better acceptance. Clinicians and administrators will answer the survey to capture their acceptability of the various aspects of the intervention.
- AppropriatenessAfter 6 months
A study specific survey will be used to measure appropriateness. Survey will have Likert-type questions, 1-5 strongly disagree to strongly agree, a higher score reflects better appropriateness. the survey will capture how well the clinicians and administrators graded the various aspects of the intervention.
- Everyday useAfter 6 months
A study specific survey will be used to measure how applicable for everyday use. Survey will have Likert-type questions, 1-5 strongly disagree to strongly agree, a higher score reflects better everyday use. The survey will capture how easy the intervention is for clinicians and administrators.